QurAlis Corp filed a Form D with the Securities and Exchange Commission on 2025-09-05.
QurAlis Corp filed a Form D notice of an exempt securities offering with the SEC on September 5, 2025. The filing reports $19.95M sold. Its industry group is Pharmaceuticals. It names Kasper Roet (Mr. Roet is the Chief Executive Officer, President and Treasurer of the Issuer.), Amy Schulman (Director), Luc Dochez (Director) (SEC Form D, September 5, 2025).
Is this your company?
Sell to companies like QurAlis Corp? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2025-09-05 · the record
Pitching, partnering or investing alongside them? See who really runs and owns QurAlis Corp.
Free to see. No signup.
More on the people and the money behind QurAlis Corp, from the filings we hold.
Pharmaceuticals raises by companies based in Massachusetts, filed within 90 days of this one, largest first.
Get an email when QurAlis Corp files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when QurAlis Corp raises, hires or launches. No email unless you switch it on.
Watch QurAlis Corp →Get the full cited report on QurAlis Corp
What the filing shows about QurAlis Corp
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on QurAlis Corp: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The filing gives QurAlis Corp's address as 35 Cambridge Park Drive, Cambridge, MA 02140.
Saved here on this device in the meantime, so nothing is lost either way.
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
QurAlis Corp is a registered filer with the SEC (CIK 1811817) and has filed since 2023-03-13. 2 filings are on record, the latest on 2025-09-05.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
QurAlis Corp's Form D of 2025-09-05 names Kasper Roet, Amy Schulman, Luc Dochez and 8 more as its officers, directors or promoters.
Its new offerings report $79.93M sold across 2 offerings, as its own filings state.
Each marker is one filing. The larger marker is the filing this page is about.
Trailing twelve months. 155 filings in Pharmaceuticals, totalled by week.
On the filing as: Director, Executive Officer, Promoter.
Kasper Roet is named as Mr. Roet is the Chief Executive Officer, President and Treasurer of the Issuer. on the Form D that QurAlis Corp filed with the SEC on 5 September 2025, one of 11 people that filing names.
Amy Schulman is named as Director on the Form D that QurAlis Corp filed with the SEC on 5 September 2025, one of 11 people that filing names.
Luc Dochez is named as Director on the Form D that QurAlis Corp filed with the SEC on 5 September 2025, one of 11 people that filing names.
Johannes Fruehauf is named as Director on the Form D that QurAlis Corp filed with the SEC on 5 September 2025, one of 11 people that filing names.
Cillian King is named as Director on the Form D that QurAlis Corp filed with the SEC on 5 September 2025, one of 11 people that filing names.
Michael Hutton is named as Director on the Form D that QurAlis Corp filed with the SEC on 5 September 2025, one of 11 people that filing names.
Anne Whitaker is named as Director on the Form D that QurAlis Corp filed with the SEC on 5 September 2025, one of 11 people that filing names.
Laia Crespo-Martin is named as Director on the Form D that QurAlis Corp filed with the SEC on 5 September 2025, one of 11 people that filing names.
On the filing as: Director, Executive Officer, Promoter.
Kasper Roet is named as Mr. Roet is the Chief Executive Officer, President, Secretary and Treasurer of the Issuer. on the Form D that QurAlis Corp filed with the SEC on 5 September 2025, one of 11 people that filing names.
On the filing as: Executive Officer.
Jason Brown is named as Mr. Brown is the Chief Financial Officer of the Issuer. on the Form D that QurAlis Corp filed with the SEC on 5 September 2025, one of 11 people that filing names.
Shafique Virani is named as Executive Officer on the Form D that QurAlis Corp filed with the SEC on 5 September 2025, one of 11 people that filing names.
11 people named on the filing — 4 holding an executive role and 7 as directors only.
Named as of the 2025-09-05 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
No investor is drawn from a Form D — the form states how many invested and never who.
What the filing shows about QurAlis Corp
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on QurAlis Corp: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on QurAlis Corp covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist QurAlis CorpYou get an alert in MentionFox the next time this company shows up.
If you're behind QurAlis Corp: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov.
Each opens in a new tab, filled in for QurAlis Corp. With no account yet, you sign up free and land on the result.
On these lists: Pharmaceuticals raises in Boston
Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.
https://mentionfox.com/funding/quralis-corp-form-d-25000001